AI assistant
Sending…
TransMedics Group, Inc. — Director's Dealing 2023
Nov 29, 2023
31201_dirs_2023-11-29_2c000513-17e6-40a4-b98c-c45ef8e4944f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TransMedics Group, Inc. (TMDX)
CIK: 0001756262
Period of Report: 2023-11-28
Reporting Person: TOBIN JAMES R (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-11-28 | Common Stock | S | 10000 | $70.14 | Disposed | 233591 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1193 | Direct |
Footnotes
F1: Includes 1,193 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
More from TransMedics Group, Inc.
Regulatory Filings
2026
May 29
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Annual Report
2026
Apr 10
Proxy Solicitation & Information Statement
2026
Apr 10
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Regulatory Filings
2026
Feb 27
Annual Report
2026
Feb 24
Earnings Release
2026
Feb 24
Director's Dealing
2026
Feb 20